Abstract
RCAN1, also known as DSCR1, is an endogenous regulator of calcineurin, a serine/threonine protein phosphatase that plays a critical role in many physiological processes. In this report, we demonstrate that p38α MAP kinase can phosphorylate RCAN1 at multiple sites in vitro and show that phospho-RCAN1 is a good protein substrate for calcineurin. In addition, we found that unphosphorylated RCAN1 noncompetitively inhibits calcineurin protein phosphatase activity and that the phosphorylation of RCAN1 by p38α MAP kinase decreases the binding affinity of RCAN1 for calcineurin. These findings reveal the molecular mechanism by which p38α MAP kinase regulates the function of RCAN1/calcineurin through phosphorylation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Musson R E, Smit N P. Regulatory mechanisms of calcineurin phosphatase activity. Curr Med Chem, 2011, 18: 301–315
Shi Y. Serine/threonine phosphatases: Mechanism through structure. Cell, 2009, 139: 468–484
Reese L C, Taglialatela G. A role for calcineurin in Alzheimer’s disease. Curr Neuropharmacol, 2011, 9: 685–692
Clipstone N A, Crabtree G R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature, 1992, 357: 695–697
Wang H G, Pathan N, Ethell I M, et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of bad. Science, 1999, 284: 339–343
Dunn S E, Burns J L, Michel R N. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem, 1999, 274: 21908–21912
Bear M F, Malenka R C. Synaptic plasticity: Ltp and ltd. Curr Opin Neurobiol, 1994, 4: 389–399
Mansuy I M, Mayford M, Jacob B, et al. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell, 1998, 92: 39–49
Molkentin J D, Lu J R, Antos C L, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 1998, 93: 215–228
Loh C, Shaw K T, Carew J, et al. Calcineurin binds the transcription factor nfat1 and reversibly regulates its activity. J Biol Chem, 1996, 271: 10884–10891
Masuda E S, Liu J, Imamura R, et al. Control of nfatx1 nuclear translocation by a calcineurin-regulated inhibitory domain. Mol Cell Biol, 1997, 17: 2066–2075
Liu J, Masuda E S, Tsuruta L, et al. Two independent calcineurin-binding regions in the n-terminal domain of murine nf-atx1 recruit calcineurin to murine nf-atx1. J Immunol, 1999, 162: 4755–4761
Martinez-Martinez S, Rodriguez A, Lopez-Maderuelo M D, et al. Blockade of NFAT activation by the second calcineurin binding site. J Biol Chem, 2006, 281: 6227–6235
Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene, 2001, 20: 2476–2489
Chang K T, Shi Y J, Min K T. The drosophila homolog of down’s syndrome critical region 1 gene regulates learning: Implications for mental retardation. Proc Natl Acad Sci USA, 2003, 100: 15794–15799
Harris C D, Ermak G, Davies K J. Rcan1-1l is overexpressed in neurons of Alzheimer’s disease patients. FEBS J, 2007, 274: 1715–1724
Baek K H, Zaslavsky A, Lynch R C, et al. Down’s syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature, 2009, 459: 1126–1130
Arron J R, Winslow M M, Polleri A, et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Na ture, 2006, 441: 595–600
Ryeom S, Baek K H, Rioth M J, et al. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell, 2008, 13: 420–431
Killilea S D, Cheng Q, Wang Z X. Protein phosphatase type 1 and type 2a assays. Methods Mol Biol, 1998, 93: 23–33
Zhang Y Y, Wu J W, Wang Z X. Mitogen-activated protein kinase (MAPK) phosphatase 3-mediated cross-talk between MAPKs ERK2 and p38alpha. J Biol Chem, 2011, 286: 16150–16162
Webb M R. A continuous spectrophotometric assay for inorganic phosphate and for measuring phosphate release kinetics in biological systems. Proc Natl Acad Sci USA, 1992, 89: 4884–4887
Sergienko E A, Srivastava D K. A continuous spectrophotometric method for the determination of glycogen phosphorylase-catalyzed reaction in the direction of glycogen synthesis. Anal Biochem, 1994, 221: 348–355
Kingsbury T J, Cunningham K W. A conserved family of calcineurin regulators. Genes Dev, 2000, 14: 1595–1604
Gorlach J, Fox D S, Cutler N S, et al. Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calci-pressin, in cryptococcus neoformans. EMBO J, 2000, 19: 3618–3629
Chan B, Greenan G, McKeon F, et al. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc Natl Acad Sci USA, 2005, 102: 13075–13080
Vega R B, Yang J, Rothermel B A, et al. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem, 2002, 277: 30401–30407
Kilka S, Erdmann F, Migdoll A, et al. The proline-rich N-terminal sequence of calcineurin abeta determines substrate binding. Biochemistry, 2009, 48: 1900–1910
Ermak G, Morgan T E, Davies K J. Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer’s disease. J Biol Chem, 2001, 276: 38787–38794
Casas C, Martinez S, Pritchard M A, et al. DSCR1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis. Mech Dev, 2001, 101: 289–292
Rothermel B, Vega R B, Yang J, et al. A protein encoded within the down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem, 2000, 275: 725
Hilioti Z, Gallagher D A, Low-Nam S T, et al. GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNS. Genes Dev, 2004, 18: 35–47
Abbasi S, Lee J D, Su B, et al. Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. J Biol Chem, 2006, 281: 7717–7726
Lee E J, Seo S R, Um J W, et al. NF-kappaB-inducing kinase phosphorylates and blocks the degradation of down syndrome candidate region 1. J Biol Chem, 2008, 283: 3392–3400
Liu Q, Busby J C, Molkentin J D. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol, 2009, 11: 154–161
Jung M S, Park J H, Ryu Y S, et al. Regulation of RCAN1 protein activity by DYRK1a protein-mediated phosphorylation. J Biol Chem, 2011, 286: 40401–40412
Kim S S, Oh Y, Chung K C, et al. Protein kinase a phosphorylates down syndrome critical region 1 (RCAN1). Biochem Biophys Res Commun, 2012, 418: 657–661
Kishi T, Ikeda A, Nagao R, et al. The SCFCDC4 ubiquitin ligase regulates calcineurin signaling through degradation of phosphorylated RCN1, an inhibitor of calcineurin. Proc Natl Acad Sci USA, 2007, 104: 17418–17423
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Ma, L., Tang, H., Ren, Y. et al. p38α MAP kinase phosphorylates RCAN1 and regulates its interaction with calcineurin. Sci. China Life Sci. 55, 559–566 (2012). https://doi.org/10.1007/s11427-012-4340-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-012-4340-9